NASDAQ: PHH
Park Ha Biological Technology Co Ltd Stock

$19.80+0.94 (+4.98%)
Updated Jun 13, 2025
PHH Price
$19.80
Fair Value Price
$2.73
Market Cap
$518.76M
52 Week Low
$3.70
52 Week High
$22.00
P/E
990x
P/B
344.44x
P/S
N/A
PEG
32.79x
Dividend Yield
N/A
Revenue
$2.38M
Earnings
$478.56k
Gross Margin
91.8%
Operating Margin
33.31%
Profit Margin
20.1%
Debt to Equity
1.05
Operating Cash Flow
$960k
Beta
-0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PHH Overview

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine PHH's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Household & Personal Product

Industry Rating
C
PHH
Ranked
#14 of 26

Top Ranked Stocks in Industry

View Top Household & Personal Product Stocks

Be the first to know about important PHH news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PHH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PHH ($19.80) is overvalued by 625.49% relative to our estimate of its Fair Value price of $2.73 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PHH ($19.80) is not significantly undervalued (625.49%) relative to our estimate of its Fair Value price of $2.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PHH ($19.80) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PHH due diligence checks available for Premium users.

Valuation

PHH fair value

Fair Value of PHH stock based on Discounted Cash Flow (DCF)

Price
$19.80
Fair Value
$2.73
Overvalued by
625.49%
PHH ($19.80) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PHH ($19.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PHH ($19.80) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PHH price to earnings (PE)

For valuing profitable companies with steady earnings

Company
990x
Industry
25.33x
Market
31.36x
PHH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PHH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

PHH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
344.44x
Industry
7.23x
PHH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PHH price to earnings growth (PEG)

For valuing profitable companies with growth potential

PHH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

PHH's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PHH's Earnings (EBIT) of $793.42k... subscribe to Premium to read more.
Interest Coverage Financials
PHH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.1M
Liabilities
$1.6M
Debt to equity
1.05
PHH's short-term assets ($2.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PHH's short-term assets ($2.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PHH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PHH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
PHH's operating cash flow ($960.47k)... subscribe to Premium to read more.
Debt Coverage Financials

PHH vs Household & Personal Product Stocks

TickerZen RatingMarket Cap1d %P/EP/B
PHHC$518.76M+4.98%990.00x344.44x
HNSTC$500.48M-4.62%-227.00x2.77x
HELEC$620.83M-3.32%5.03x0.37x
NUSA$373.56M-5.38%-9.82x0.50x
EWCZB$316.88M-4.81%28.70x4.50x

Park Ha Biological Technology Co Stock FAQ

What is Park Ha Biological Technology Co's quote symbol?

(NASDAQ: PHH) Park Ha Biological Technology Co trades on the NASDAQ under the ticker symbol PHH. Park Ha Biological Technology Co stock quotes can also be displayed as NASDAQ: PHH.

If you're new to stock investing, here's how to buy Park Ha Biological Technology Co stock.

What is the 52 week high and low for Park Ha Biological Technology Co (NASDAQ: PHH)?

(NASDAQ: PHH) Park Ha Biological Technology Co's 52-week high was $22.00, and its 52-week low was $3.70. It is currently -10% from its 52-week high and 435.14% from its 52-week low.

How much is Park Ha Biological Technology Co's stock price per share?

(NASDAQ: PHH) Park Ha Biological Technology Co stock price per share is $19.80 today (as of Jun 13, 2025).

What is Park Ha Biological Technology Co's Market Cap?

(NASDAQ: PHH) Park Ha Biological Technology Co's market cap is $518.76M, as of Jun 15, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Park Ha Biological Technology Co's market cap is calculated by multiplying PHH's current stock price of $19.80 by PHH's total outstanding shares of 26,200,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.